Literature DB >> 9565714

Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation.

M T Hegel1, L E Griegel, C Black, L Goulden, T Ozahowski.   

Abstract

OBJECTIVE: The implantable cardioverter-defibrillator (ICD) has dramatically improved survival rates following sudden cardiac death episodes. However, researchers have devoted little attention to the psychosocial consequences of living with the device. The current study used a longitudinal design to evaluate the impact of adaptation to the ICD on incidence and severity of anxiety and depression.
METHOD: ICD recipients were administered standardized anxiety and depression questionnaires as well as questions evaluating quality of life related to the ICD in two consecutive yearly assessments. A preliminary evaluation of potentially important theoretical variables, such as the perceived predictability and controllability of shock onset was also conducted.
RESULTS: One-third of the study population (N = 38) had clinically significant levels of anxiety, depressed mood, and fear of symptoms of autonomic arousal. These negative affective states persisted over time, with 40 to 63 percent of subjects continuing to have ongoing difficulties over a one-year time period. Anxiety about the ICD firing was closely associated with the occurrence of depression, while avoidance of activities was associated with anxiety. "Worry" about the ICD and a belief that ICD firing can be predicted were associated with anxiety sensitivity.
CONCLUSIONS: Depressive and anxiety states in ICD recipients may be frequent, clinically significant, and resistant to spontaneous resolution. Early signs of anxiety and depression in ICD recipients should be evaluated. Implications for future research are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9565714     DOI: 10.2190/1G9V-EQMD-MTLQ-E0BW

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  16 in total

1.  Psychological indices and phantom shocks in patients with ICD.

Authors:  Liza A Prudente; Juanita Reigle; Cheryl Bourguignon; David E Haines; John P DiMarco
Journal:  J Interv Card Electrophysiol       Date:  2006-08-04       Impact factor: 1.900

Review 2.  Athletes with Implantable Cardioverter Defibrillators.

Authors:  Shiva P Ponamgi; Christopher V DeSimone; Michael J Ackerman
Journal:  Clin Sports Med       Date:  2015-07       Impact factor: 2.182

3.  How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?

Authors:  F Duru; S Büchi; R Klaghofer; H Mattmann; T Sensky; C Buddeberg; R Candinas
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

4.  Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: the Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial.

Authors:  Rebecca G Donahue; Rachel Lampert; Ellen Dornelas; Lynn Clemow; Matthew M Burg
Journal:  Psychosom Med       Date:  2009-12-22       Impact factor: 4.312

5.  Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators.

Authors:  Jennifer L Francis; Ali A Weinstein; David S Krantz; Mark C Haigney; Phyllis K Stein; Peter H Stone; John S Gottdiener; Willem J Kop
Journal:  Psychosom Med       Date:  2009-08-06       Impact factor: 4.312

6.  Exercise Interventions in Patients With Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Daniel A Steinhaus; Steven A Lubitz; Peter A Noseworthy; Daniel B Kramer
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-09       Impact factor: 2.081

7.  The impact of an implantable cardioverter defibrillator: the Leiden follow-up study of ICD patients and their partners.

Authors:  N M S de Groot; M Bootsma; E E van der Wall; M J Schalij
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

Review 8.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

9.  Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Authors:  A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 10.  Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review.

Authors:  Elena Salmoirago-Blotcher; Ira S Ockene
Journal:  BMC Cardiovasc Disord       Date:  2009-12-29       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.